Clinical Trials Directory

Trials / Sponsors / SciClone Pharmaceuticals

SciClone Pharmaceuticals

Industry · 16 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
WithdrawnA Real-World Study in Patients With HR+/HER2- Advanced Breast Cancer
Breast Cancer Metastatic, HR+/HER2- Advanced Breast Cancer
—2025-08-01
RecruitingCurrent Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer
ESR1 Gene Mutation, Advanced Breast Cancer
—2024-08-08
RecruitingSafety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC
ESR1 Gene Mutation, Advanced Breast Cancer, Safety
—2024-07-13
Not Yet RecruitingNaxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Mainten
Neuroblastoma
Phase 42023-10-31
UnknownPT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors
Biliary Tract Cancer
Phase 1 / Phase 22020-04-13
UnknownAn Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellu
Advanced Solid Tumors
Phase 1 / Phase 22018-03-07
UnknownFirst Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Sma
EGFR Mutation Positive Non Small Cell Lung Cancer
Phase 1 / Phase 22016-10-01
UnknownThymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Smal
Non-Small Cell Lung Cancer
Phase 22016-09-01
UnknownStudy to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in
Oral Mucositis
Phase 22010-12-01
CompletedExtension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Co
Chronic Hepatitis C
—2010-08-01
CompletedProof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Comb
Chronic Hepatitis C
Phase 22009-09-01
CompletedDose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis
Oral Mucositis, Head and Neck Cancer
Phase 22008-09-01
TerminatedPhase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
Pancreatic Cancer
Phase 22007-09-01
CompletedThymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Inter
Hepatitis C, Hepatitis C, Chronic
Phase 32002-05-01
CompletedThymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interf
Hepatitis C, Hepatitis C, Chronic
Phase 32002-04-01
CompletedA Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
Carcinoma, Hepatocellular
Phase 2—